We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

122 hedge funds and large institutions have $532M invested in Array Biopharma Inc in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 41 increasing their positions, 42 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 42

7% less capital invested

Capital invested by funds: $571M → $532M (-$38.6M)

15% less funds holding

Funds holding: 143 → 122 (-21)

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

66% less call options, than puts

Call options by funds: $1.61M | Put options by funds: $4.79M

76% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 25

Holders
122
Holders Change
-21
Holders Change %
-14.69%
% of All Funds
3.52%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.12%
New
6
Increased
41
Reduced
42
Closed
25
Calls
$1.61M
Puts
$4.79M
Net Calls
-$3.18M
Net Calls Change
+$526K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$4.89M
2
DM
Deerfield Management
New York
+$4.88M
3
BI
BVF Inc
California
+$4.7M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$4.37M
5
State Street
State Street
Massachusetts
+$3.05M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.77M
2
GC
GMT Capital
Georgia
-$2.52M
3
GC
Guggenheim Capital
Illinois
-$2.42M
4
QF
QVT Financial
New York
-$1.9M
5
Renaissance Technologies
Renaissance Technologies
New York
-$1.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
NI
126
Numeric Investors
Massachusetts
– -$1.48M -295,406 Closed
IHM
127
Iguana Healthcare Management
New York
– -$1M -200,000 Closed
Two Sigma Investments
128
Two Sigma Investments
New York
– -$939K -187,453 Closed
PCP
129
Perimeter Capital Partners
Georgia
– -$908K -181,321 Closed
State of Tennessee, Department of Treasury
130
State of Tennessee, Department of Treasury
Tennessee
– -$301K -60,000 Closed
OAM
131
Oxford Asset Management
United Kingdom
– -$261K -52,163 Closed
JG
132
Jefferies Group
New York
– -$251K -50,000 Closed
Invesco
133
Invesco
Georgia
– -$194K -38,684 Closed
D.E. Shaw & Co
134
D.E. Shaw & Co
New York
– -$190K -37,935 Closed
DTL
135
Dynamic Technology Lab
Singapore
– -$132K -26,410 Closed
Nomura Holdings
136
Nomura Holdings
Japan
– -$129K -26,011 Closed
Verition Fund Management
137
Verition Fund Management
Connecticut
– -$103K -20,513 Closed
HI
138
HBK Investments
Texas
– -$83K -16,600 Closed
T
139
TradeWorx
New Jersey
– -$68K -13,480 Closed
CEP
140
Chicago Equity Partners
Illinois
– -$63K -12,575 Closed
ERIM
141
Eagle Ridge Investment Management
Connecticut
– -$50K -10,000 Closed
FMT
142
First Mercantile Trust
Tennessee
– -$28K -5,647 Closed
BNP Paribas Financial Markets
143
BNP Paribas Financial Markets
France
– -$7.59K -1,515 Closed
MAS
144
Madden Advisory Services
Florida
– -$2K -300 Closed
EWM
145
Elite Wealth Management
Washington
– -$1K -132 Closed
Fifth Third Bancorp
146
Fifth Third Bancorp
Ohio
– -$1K -117 Closed
2 3 4 5
6

ARRY Hedge Fund Activity: Q1 2014 in Review

122 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q1 2014, worth a combined $532M — down 6.8% from $571M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ARRY and 6 opened new positions — a net loss of 19 holders — while 42 trimmed existing stakes and 41 added.

The largest buyer was OrbiMed, adding an estimated $4.89M. The largest seller was Millennium Management, cutting an estimated $2.77M.

  • 122 institutional investors held Array Biopharma Inc (ARRY) as of Q1 2014, down from 143 in Q4 2013.
  • Funds reported $532M of Array Biopharma Inc stock for Q1 2014, down 6.8% quarter-over-quarter.
  • 6 funds opened new Array Biopharma Inc positions in Q1 2014 and 25 closed out, a net change of -19 holders.
  • The largest Array Biopharma Inc buyer in Q1 2014 was OrbiMed, an estimated $4.89M added.
  • The largest Array Biopharma Inc seller in Q1 2014 was Millennium Management, an estimated $2.77M sold.

Based on aggregated 13F filings for Q1 2014.